Diabetes and Obesity Bias: Are We Intensifying the Pharmacological Treatment in Patients With and Without Obesity With Equity?-Reference-Cited by-同舟云学术

Diabetes and Obesity Bias: Are We Intensifying the Pharmacological Treatment in Patients With and Without Obesity With Equity?

Published:2021-10-08 Issue:12 Volume:44 Page:e206-e208
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Alessi Janine¹²^ORCID,de Oliveira Giovana B.³,Erthal Isadora Nunes³,Teixeira Julia Belato³,Scherer Gabriela D.L.G.³,Jaeger Eduarda Herscovitz³,Schneiders Josiane¹,Telo Guilherme H.⁴,Schaan Beatriz D.¹⁵⁶,Telo Gabriela H.³⁴⁷

Affiliation:

1. Postgraduate Program in Endocrinology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil

2. Endocrinology Divison, Hospital São Lucas – Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil

3. School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil

4. Medicine and Health Sciences Graduate Program, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil

5. School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil

6. Endocrinology Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil

7. Internal Medicine Division, Hospital São Lucas – Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/44/12/e206/631607/dc211294.pdf

Reference5 articles.

1. Impact of weight stigma on physiological and psychological health outcomes for overweight and obese adults: a systematic review;Wu;J Adv Nurs,2018

2. Obesity bias in training: attitudes, beliefs, and observations among advanced trainees in professional health disciplines;Puhl;Obesity (Silver Spring),2014

3. The rational treatment of diabetes mellitus in older adults: the adequacy of treatment decisions based on individualized glycemic targets in primary and tertiary care;Alessi;J Diabetes Complications,2021

4. Understanding the impact of commonly utilized, non-insulin, glucose-lowering drugs on body weight in patients with type 2 diabetes;Hurren;Expert Opin Pharmacother,2018

5. Coverage, formulary restrictions, and out-of-pocket costs for sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in the Medicare Part D program;Luo;JAMA Netw Open,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hidden barriers: obesity bias in hypertension treatment;International Journal of Obesity;2024-08-19

2. The impact of overweight on lipid phenotype in different forms of dyslipidemia: a retrospective cohort study;Journal of Endocrinological Investigation;2024-04-11

3. Obesity bias: How can this underestimated problem affect medical decisions in healthcare? A systematic review;Obesity Reviews;2024-01-25

4. Ethics and Fairness for Diabetes Artificial Intelligence;Diabetes Digital Health, Telehealth, and Artificial Intelligence;2024

5. Obesity Stigma: Causes, Consequences, and Potential Solutions;Current Obesity Reports;2023-02-14